MedPacto (Korea) Price Prediction
| 235980 Stock | KRW 5,440 270.00 5.22% |
Oversold Vs Overbought
25
Oversold | Overbought |
Using MedPacto hype-based prediction, you can estimate the value of MedPacto from the perspective of MedPacto response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in MedPacto to buy its stock at a price that has no basis in reality. In that case, they are not buying MedPacto because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MedPacto after-hype prediction price | KRW 5170.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
MedPacto |
MedPacto After-Hype Price Prediction Density Analysis
As far as predicting the price of MedPacto at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MedPacto or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MedPacto, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MedPacto Estimiated After-Hype Price Volatility
In the context of predicting MedPacto's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MedPacto's historical news coverage. MedPacto's after-hype downside and upside margins for the prediction period are 5,166 and 5,174, respectively. We have considered MedPacto's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MedPacto is very steady at this time. Analysis and calculation of next after-hype price of MedPacto is based on 3 months time horizon.
MedPacto Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as MedPacto is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MedPacto backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MedPacto, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.33 | 3.65 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5,440 | 5,170 | 0.00 |
|
MedPacto Hype Timeline
MedPacto is presently traded for 5,440on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. MedPacto is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.33%. %. The volatility of related hype on MedPacto is about 0.0%, with the expected price after the next announcement by competition of 5,440. About 34.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. MedPacto had 2:1 split on the 13th of May 2020. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out MedPacto Basic Forecasting Models to cross-verify your projections.MedPacto Related Hype Analysis
Having access to credible news sources related to MedPacto's direct competition is more important than ever and may enhance your ability to predict MedPacto's future price movements. Getting to know how MedPacto's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MedPacto may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 207940 | Samsung Biologics Co | 0.00 | 0 per month | 1.21 | (0.08) | 2.57 | (2.47) | 8.27 | |
| 326030 | Sk Biopharmaceuticals Co | 0.00 | 0 per month | 0.00 | (0.08) | 5.62 | (4.05) | 12.81 | |
| 298380 | ABL Bio | 0.00 | 0 per month | 0.00 | (0.06) | 6.60 | (6.19) | 26.64 | |
| 144510 | Green Cross Lab | 0.00 | 0 per month | 0.00 | (0.17) | 4.49 | (4.88) | 16.03 | |
| 235980 | MedPacto | 0.00 | 0 per month | 0.00 | (0.16) | 3.93 | (5.49) | 18.66 | |
| 334970 | Prestige Biologics Co | 0.00 | 0 per month | 0.00 | (0.12) | 6.39 | (4.93) | 18.21 | |
| 244460 | OLIPASS | 0.00 | 0 per month | 5.38 | 0.03 | 12.36 | (7.46) | 48.64 | |
| 086890 | ISU Abxis Co | 0.00 | 0 per month | 0.00 | (0.31) | 2.88 | (4.35) | 8.39 |
MedPacto Additional Predictive Modules
Most predictive techniques to examine MedPacto price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MedPacto using various technical indicators. When you analyze MedPacto charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MedPacto Predictive Indicators
The successful prediction of MedPacto stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MedPacto, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MedPacto based on analysis of MedPacto hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MedPacto's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MedPacto's related companies.
Story Coverage note for MedPacto
The number of cover stories for MedPacto depends on current market conditions and MedPacto's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MedPacto is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MedPacto's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
MedPacto Short Properties
MedPacto's future price predictability will typically decrease when MedPacto's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MedPacto often depends not only on the future outlook of the potential MedPacto's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MedPacto's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.5 M | |
| Cash And Short Term Investments | 121.6 B | |
| Shares Float | 13.1 M |
Complementary Tools for MedPacto Stock analysis
When running MedPacto's price analysis, check to measure MedPacto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedPacto is operating at the current time. Most of MedPacto's value examination focuses on studying past and present price action to predict the probability of MedPacto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedPacto's price. Additionally, you may evaluate how the addition of MedPacto to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |